Intranasal Delivery of Testosterone and Its Effect on Doping Markers

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 18, 2015

Primary Completion Date

January 19, 2016

Study Completion Date

January 19, 2016

Conditions

Abuse of Anabolic Steroids

Interventions

DRUG

Testosterone

Participants will self-administer 11 mg 3x daily, for 5 consecutive days for 4 weeks.

Trial Locations (1)

University of Utah Orthopaedic Center, Salt Lake City

All Listed Sponsors

collaborator

Sports Medicine Research and Testing Laboratory

INDUSTRY

collaborator

Partnership for Clean Competition

OTHER

lead

University of Utah

OTHER

NCT02611154 - Intranasal Delivery of Testosterone and Its Effect on Doping Markers | Biotech Hunter | Biotech Hunter